India  

SII, Bharat Biotech seek hike in government price for Covid vaccines

IndiaTimes Tuesday, 15 June 2021
Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals is already high. The Centre’s procurement price has been in the range of Rs 150-200 per jab, for the orders placed with the companies from January onwards.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

Sputnik V vaccine production in India to go fully on stream in September: RDIF

The production of Sputnik V in India is expected to come fully on stream in September. "Production in India is expected to come fully onstream in September and..
IndiaTimes
Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News [Video]

Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News

Today, the health ministry said that the predictions about the third wave of Covid should be taken very seriously; Sources in the Serum Institute of India said that the production of Covishield has been ramped up to around 110 million doses this month; Today, the Finance Ministry said that keeping in mind the growing demand for holding clerical cadre examinations in public sector banks in local or regional languages, a committee has been formed to look into the matter; Today, Congress slammed the Centre over the surge of prices of petrol and diesel in the country. #CovidThirdWave #Predictions #CovidNorms

Credit: Oneindia    Duration: 02:37Published
India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia [Video]

India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia

Serum Institute of India's Covishield vaccine has been approved in seven European Union nations and Switzerland amid a row over travel pass. Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are confirmed as including Covishield. #EU #Covidshield #Covid19

Credit: Oneindia    Duration: 02:02Published
SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News [Video]

SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News

The Subject Expert Committee of the Central Drugs Standard Control Organisation did not approve Serum Institute of India’s request to allow clinical trials of its second Covid vaccine in children. #SII #CDSCO #Covovax

Credit: Oneindia    Duration: 01:31Published
Covishield cleared by 7 EU nations, Switzerland for travellers amid row | Oneindia News [Video]

Covishield cleared by 7 EU nations, Switzerland for travellers amid row | Oneindia News

Seven European Union countries - Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain - and Switzerland have cleared the Serum Institute of India's Covishield amid travel pass row, sources have said; Elections every few years to change the ruler need not be a guarantee against tyranny of those elected, Chief Justice of India NV Ramana said at a function; A National Investigation Agency court Thursday discharged Assam MLA Akhil Gogoi in the only pending UAPA and sedition case against him. All this and more news at 2 PM. #Covishield #VaccinePass #JusticeRamana

Credit: Oneindia    Duration: 02:47Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Covaxin output set to rise; govt hopes to meet 135 crore-dose goal

Indian Immunologicals Limited is likely to start supply of an additional 2 million doses of Covaxin from August-September, whereas Bharat Biotech’s Ankleshwar..
IndiaTimes

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
IndiaTimes

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
IndiaTimes
PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News [Video]

PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News

Today, the Monsoon session of the Lok Sabha began on a chaotic note with the opposition preventing Prime Minister Narendra Modi from introducing his newly-inducted Union ministers to the House; The second dose of Bharat Biotech's Covaxin for children aged 2-6 years, is likely to be administered to those participating in the trials next week; Amid the ongoing military standoff with China in eastern Ladakh, Indian agencies are closely monitoring the development of a Chinese airbase in Shakche; Today, Delhi Chief Minister Arvind Kejriwal said that a 'world-class drainage system' will be developed across the national capital. #MonsoonSession #Opposition #PMModi

Credit: Oneindia    Duration: 02:22Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Covid-19: the delta variant is challenging China's costly strategy of isolating cities [Video]

Covid-19: the delta variant is challenging China's costly strategy of isolating cities

Credit: FRANCE 24 English    Duration: 02:38Published
WHO calls for COVID booster jab moratorium to accelerate vaccination in poorer countries [Video]

WHO calls for COVID booster jab moratorium to accelerate vaccination in poorer countries

The head of the UN agency stressed that "hundreds of millions" worldwide are still waiting for their first dose.

Credit: Euronews English    Duration: 01:59Published

Covid-19: India records 42,982 new cases, 533 deaths in last 24 hours

India saw a single day rise of 42,982 new coronavirus infections taking the total tally of Covid-19 cases to 3,18,12,114, while the active cases increased to..
IndiaTimes

COVID-19 travel advisory: UK to move India from' Red list' to 'Amber list', know new rules

"India will move to the amber list 4 am, Sunday 8 August (local time)," the UK government said.
DNA

COVID-19: Delhi government revises rates for RT-PCR, Rapid Antigen Tests, check new prices

As per the revised rates, both the RT-PCR test and RAT will now cost Rs 300 in Delhi when samples are collected by teams sent by the government.
DNA

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Vaccine against COVID-19

Creator of Oxford vaccine made into Barbie doll [Video]

Creator of Oxford vaccine made into Barbie doll

Professor Dame Sarah Gilbert has been honoured as a ‘Barbie Role Model’ for her work creating the Oxford vaccine.It is hoped the Barbie doll will inspire girls to consider a career in science.

Credit: PA - Press Association STUDIO    Duration: 01:07Published
Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News [Video]

Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News

Top political leaders today expressed anguish over the allegedrape and murderof a nine-year-old Dalit girl in the Delhi Cantonment area on Sunday. The government has said today that the pandemic is still raging in the country and eight states have shown a rise in the R-factor, calling it a significant problem. The monthly production capacity of Covishield is projected to be increased to more than 120 million doses and of Covaxin to around 58 million doses by December, the government told Rajya Sabha today, citing information from the COVID-19 vaccine manufacturers. The United Arab Emirates will lift a ban on transit passenger traffic from India, Pakistan, Nigeria and other countries from August 5, the country's National Emergency and Crisis Management Authority said on Tuesday. #Covid19 #Coronavirus #DalitGirlRape

Credit: Oneindia    Duration: 03:00Published

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield

An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a..
IndiaTimes

Covishield generates 93% protection, says AFMC study

Covishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta..
IndiaTimes

Covishield reduces fresh infections by 93%, deaths by 98%: AFMS study

A study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the..
IndiaTimes

Covaxin Covaxin Vaccine against COVID-19

You Might Like


Related videos from verified sources

Gounder: 'Vaccines are how we learn to live' with Covid [Video]

Gounder: 'Vaccines are how we learn to live' with Covid

Dr. Celine Gounder warns that some health officials and news outlets have been “declaring ‘mission accomplished’ much too soon.” Covid will be a fact of life for the foreseeable future: “We..

Credit: Bleacher Report AOL     Duration: 03:11Published
Assam-Mizoram border situation under control, CRPF troops deployed: Centre | Oneindia News [Video]

Assam-Mizoram border situation under control, CRPF troops deployed: Centre | Oneindia News

Covid vaccines for children are likely in a matter of days, Prime Minister Narendra Modi was told this morning at a meeting of BJP MPs at parliament. Prime Minister Narendra Modi on Tuesday attacked..

Credit: Oneindia     Duration: 02:21Published
Why haven't COVID-19 vaccines gotten full approval yet? [Video]

Why haven't COVID-19 vaccines gotten full approval yet?

The COVID-19 vaccines have been widely available for months, but none of them have actually gotten full approval from the Food and Drug Administration. It also comes as the government is encouraging..

Credit: KTNV Channel 13 Las Vegas     Duration: 02:57Published

Related news from verified sources

Brazil approves imports of Russia’s Sputnik V, India’s Covaxin vaccines


Indian Express Also reported by •newKerala.comIndiaTimesZee News

India's Covaxin effectively neutralises Delta variant of Covid, says NIH


IndiaTimes

Covaxin: Frequently asked questions about India's homegrown Covid-19 vaccine

On January 16 this year, India started its biggest vaccination programme against Covid-19. For the vaccination, India gave emergency approval to two vaccines. Of...
IndiaTimes